SIGA - Monkeypox plays indicate further upside as global toll climbs

Pharma companies focused on vaccines and therapeutics against the smallpox virus surged this week amid an ongoing outbreak of its close relative, monkeypox. However, their recent price performance and valuations suggest further upside ahead. The World Health Organization said on Friday that over 80 cases of monkeypox have been confirmed in at least 12 countries. Another 50 suspected cases are currently under investigation, according to the global body, which called the recent outbreaks “atypical as they are occurring in non-endemic countries.” Meanwhile, the officials in New York said Friday they were monitoring a suspected case of monkeypox in the city. The U.S. confirmed its first monkeypox infection on Wednesday following reports of scattered cases in Europe. Monkeypox is a rare viral disease endemic in Nigeria, the Democratic Republic of the Congo, and the Central African Republic. While the virus does not readily spread between humans, smallpox vaccines can offer 85% effectiveness in

For further details see:

Monkeypox plays indicate further upside as global toll climbs